• 1
    Hall JG, Friedman JM, Kenna BA, et al. Clinical, genetic and epidemiological factors in neural tube defects. Am J Hum Genet 1988;43: 82737.
  • 2
    Elwood JM, Little J, Elwood JH. Epidemiology and control of neural tube defects. New York : Oxford University Press, 1992.
  • 3
    Hall JG, Solehdin F. Genetics of neural tube defects. Ment Retard Dev Disabil Res Rev 1998;4: 26981.
  • 4
    Online Mendelian Inheritance in Man, OMIM. McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University ( Baltimore , MD ) and National Center for Biotechnology Information, National Library of Medicine ( Bethesda , MD ), 2000. World Wide Web URL:
  • 5
    Holmes LB, Driscoll SG, Atkins L. Etiologic heterogeneity of neural tube defects. N Engl J Med 1976;294: 3659.
  • 6
    Creasy MR, Alberman ED. Congenital malformations of the central nervous system in spontaneous abortions. J Med Genet 1976;13: 916.
  • 7
    Byrne J, Warburton D. Neural tube defects in spontaneous abortions. Am J Med Genet 1986;25: 32733.
  • 8
    McFadden DE, Kalousek DK. Survey of neural tube defects in spontaneously aborted embryos. Am J Med Genet 1989;32: 3568.
  • 9
    Pietrzyk JJ. Neural tube malformations: complex segregation analysis and recurrence risk. Am J Med Genet 1980: 7: 293300.
  • 10
    Demenais F, Le Merrer M, Briard ML, Elston RC. Neural tube defects in France: segregation analysis. Am J Med Genet 1982;11: 28798.
  • 11
    Lalouel JM, Morton NE, Jackson J. Neural tube malformations: complex segregation analysis and calculation of recurrence risks. J Med Genet 1979;16: 813.
  • 12
    Carter CO, David PA, Laurence KM. A family study of major central nervous system malformations in South Wales. J Med Genet 1968;5: 81106.
  • 13
    Chatkupt S, Skurnick JH, Jaggi M, et al. Study of genetics, epidemiology and vitamin usage in familial spina bifida in the United States in the 1990s. Neurology 1994;44: 6570.
  • 14
    MacHenry JCRM, Nevin NC, Merrett JD. Comparison of central nervous system malformations in spontaneous abortions in Northern Ireland and south-east England. Br Med J 1979;1: 13957.
  • 15
    Gucciardi E, Pietrusiak M-A, Reynolds DL, Rouleau J. Incidence of neural tube defects in Ontario, 1986–1999. CMAJ 2002;167: 23740.
  • 16
    Record RG, McKeown T. Congenital malformations of the central nervous system I: a survey of 930 cases. Br J Soc Med 1949;4: 183219.
  • 17
    MacMahon B, Record RG, McKeown T. Secular changes in the incidence of malformations of the central nervous system. Br J Soc Med 1951;5: 2548.
  • 18
    Leck I. Changes in the incidence of neural-tube defects. Lancet 1966;2: 7913.
  • 19
    Rosano A, Smithells D, Cacciani L, et al. Time trends in neural tube defect prevalence in relation to preventative strategies: an international study. J Epidemiol Community Health 1999;53: 6305.
  • 20
    Leck I, Rogers SC. Changes in the incidence of anencephalus. Br J Prev Soc Med 1967;21: 17780.
  • 21
    Elwood JH, MacKenzie G. Comparisons of secular and seasonal variations in the incidence of anencephalus in Belfast and four Scottish cities. Br J Prev Soc Med 1971;25: 1725.
  • 22
    Stone DH, Smalls MJ, Rosenberg K, Womersley J. Screening for congenital neural tube defects in a high-risk area: an epidemiological perspective. J Epidemiol Community Health 1988;42: 2713.
  • 23
    Elwood JH. Epidemics of anencephalus and spina bifida in Ireland since 1900. Int J Epidemiol 1973;2: 1715.
  • 24
    Coffey VP. Neural tube defects in Dublin, 1953–1954 and 1961–1982. Ir Med J 1983;76: 4113.
  • 25
    MacMahon B, Yen S. Unrecognised epidemic of anencephaly and spina bifida. Lancet 1971;1: 313.
  • 26
    Janerich DT. Epidemic waves in the prevalence of anencephaly and spina bifida in New York State. Teratology 1973;8: 2536.
  • 27
    Canfield MA, Annegers JF, Brender JD, Cooper SP, Greenberg F. Hispanic origin and neural tube defects in Houston/Harris County, Texas. II. Risk factors. Am J Epidemiol 1996;143: 1224.
  • 28
    Shaw GM, Velie EM, Wasserman CR. Risk for neural tube defect-affected pregnancies among women of Mexican descent and white women in California. Am J Public Health 1997;87: 146771.
  • 29
    Mills JL, Simpson JL, Rhoads GG, et al. Risk of neural tube defects in relation to maternal fertility and fertility drug use. Lancet 1990;336: 1034.
  • 30
    Todoroff K, Shaw GM. Prior spontaneous abortion, prior elective termination, interpregnancy interval, and risk of neural tube defects. Am J Epidemiol 2000;151: 50511.
  • 31
    Windham GC, Sever LE. Neural tube defects among twin births. Am J Hum Genet 1982;34: 98898.
  • 32
    Windham GC, Bjerkedal T. Malformations in twins and their siblings, Norway, 1967–79. Acta Genet Med Gemellol (Roma) 1984;33: 8795.
  • 33
    Garabedian BH, Fraser FC. A familial association between twinning and upper-neural tube defects. Am J Hum Genet 1994;55: 10503.
  • 34
    Kallen B, Cocchi G, Knudsen LB, et al. International study of sex ratio and twinning of neural tube defects. Teratology 1994;50: 32231.
  • 35
    Watkins ML, Scanlon KS, Mulinare J, Khoury MJ. Is maternal obesity a risk factor for anencephaly and spina bifida? Epidemiology 1996;7: 50712.
  • 36
    Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect–affected pregnancies among obese women. JAMA 1996;275: 10936.
  • 37
    Hendricks KA, Nuno OM, Suarez L, Larsen R. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology 2001;12: 6305.
  • 38
    Lynberg MC, Khoury MJ, Lu X, Cocian T. Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study. Am J Epidemiol 1994;140: 24455.
  • 39
    Shaw GM, Todoroff K, Velie EM, Lammer EJ. Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology 1998;57: 17.
  • 40
    Kurppa K, Holmberg PC, Kuosma E, Aro T, Saxen L. Anencephaly and maternal common cold. Teratology 1991;44: 515.
  • 41
    Milunsky A, Ulcickas M, Rothman KJ, Willett W, Jick SS, Jick H. Maternal heat exposure and neural tube defects. JAMA 1992;268: 8825.
  • 42
    Brender J, Suarez L, Hendricks K, Baetz RA, Larsen R. Parental occupation and neural tube defect–affected pregnancies among Mexican Americans. J Occup Environ Med 2002;44: 6506.
  • 43
    Blatter BM, Roeleveld N. Spina bifida and parental occupation in a Swedish register-based study. Scand J Work Environ Health 1996;22: 4337.
  • 44
    Blatter BM, Roeleveld N, Zielhuis GA, Gabreels FJ, Verbeek AL. Maternal occupational exposure during pregnancy and the risk of spina bifida. Occup Environ Med 1996;53: 806.
  • 45
    Blatter BM, Roeleveld N, Bermejo E, Martinez-Frias ML, Siffel C, Czeizel AE. Spina bifida and parental occupation: results from three malformation monitoring programs in Europe. Eur J Epidemiol 2000;16: 34351.
  • 46
    Brender JD, Suarez L. Paternal occupation and anencephaly. Am J Epidemiol 1990;131: 51721.
  • 47
    Kallen K. Maternal smoking, body mass index, and neural tube defects. Am J Epidemiol 1998;147: 110311.
  • 48
    Correa A, Stolley A, Liu Y. Prenatal tea consumption and risks of anencephaly and spina bifida. Ann Epidemiol 2000;10: 4767.
  • 49
    Parkinson CE, Tan JC, Gal I. Vitamin A concentration in amniotic fluid and maternal serum related to neural-tube defects. Br J Obstet Gynaecol 1982;89: 9359.
  • 50
    Bound JP, Harvey PW, Francis BJ, Awwad F, Gatrell AC. Involvement of deprivation and environmental lead in neural tube defects: a matched case-control study. Arch Dis Child 1997;76: 10712.
  • 51
    Shaw GM, Todoroff K, Schaffer DM, Selvin S. Periconceptional nutrient intake and risk for neural tube defect-affected pregnancies. Epidemiology 1999;10: 7116.
  • 52
    Hwang BF, Magnus P, Jaakkola JJ. Risk of specific birth defects in relation to chlorination and the amount of natural organic matter in the water supply. Am J Epidemiol 2002;15;156: 37482.
  • 53
    Hibbard ED, Smithells RW. Folic acid metabolism and human embryopathy. Lancet 1965;1: 12546.
  • 54
    Emery AEH, Timson J, Watson-Williams EJ. Pathogenesis of spina bifida[Letter]. Lancet 1969;2: 90910.
  • 55
    Bower C, Stanley FJ. Dietary folate as a risk factor for neural tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989;150: 6139.
  • 56
    Molloy AM, Kirke P, Hillary I, Weir DG, Scott JM. Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects. Arch Dis Child 1985;60: 6605.
  • 57
    Winship KA, Cahal DA, Weber JCP, Griffin JP. Maternal drug histories and central nervous system abnormalities. Arch Dis Child 1984;59: 105260.
  • 58
    Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260: 31415.
  • 59
    Mills JL, Rhoads GG, Simpson JL, et al. The absence of a relation between the periconceptional use of vitamins and neural tube defects. N Engl J Med 1989;321: 4305.
  • 60
    Bower C, Stanley FJ. Periconceptional vitamin supplementation and neural tube defects; evidence from a case-control study in Western Australia and a review of recent publications. J Epidemiol Community Health 1992;46: 15761.
  • 61
    Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269: 125761.
  • 62
    Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6: 21926.
  • 63
    Schorah CJ, Wild J, Hartley R, Sheppard S, Smithells RW. The effect of periconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defects. Br J Nutr 1983;49: 20311.
  • 64
    Yates JRW, Ferguson-Smith MA, Shenkin A, Guzman-Rodriguez R, White M, Clark BJ. Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin Genet 1987;31: 27987.
  • 65
    Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262: 284752.
  • 66
    Smithells RW, Sheppard S, Schorah CJ, et al. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet 1980;1: 33940.
  • 67
    Smithells RW, Sheppard S, Schorah CJ, et al. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 1981;56: 9118.
  • 68
    Smithells RW, Nevin NC, Seller MJ, et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983;1: 102731.
  • 69
    Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. Br Med J 1981;282: 150911.
  • 70
    Laurence KM, Campbell H, James NE. The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. In: DobbingJ, ed. Prevention of spina bifida and other neural tube defects. London : Academic Press, 1983: 85106.
  • 71
    Berry RJ, Li Z, Erickson JD, et al. Prevention of neural tube defects with folic acid in China. N Engl J Med 1999;341: 148590.
  • 72
    Berry RJ, Li A. Folic acid alone prevents neural tube defects: evidence from the China study. Epidemiology 2002;13: 1146.
  • 73
    Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327: 18325.
  • 74
    Czeizel AE, Dudas I, Metneki J. Pregnancy outcomes in a randomized controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet 1994;255: 1319.
  • 75
    MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 1991;338: 1317.
  • 76
    Prevention program for reducing risk for neural tube defects—South Carolina, 1992–1994. MMWR Morb Mortal Wkly Rep 1995;44: 1412.
  • 77
    Felkner M, Suarez L, Hendricks K, Gunter EW. Blood folate levels on the Texas–Mexico border. Tex Med 2002;98: 5860.
  • 78
    Caudill MA, Le T, Moonie SA, Esfahani ST, Cogger EA. Folate status in women of childbearing age residing in Southern California after folic acid fortification. J Am Coll Nutr 2001;20(suppl 2):12934.
  • 79
    Suarez L, Hendricks KA, Cooper SP, Sweeney AM, Hardy RJ, Larsen RD. Neural tube defects among Mexican Americans living on the US–Mexico border: effects of folic acid and dietary folate. Am J Epidemiol 2000;152: 101723.
  • 80
    Folate status in women of childbearing age, by race/ethnicity—United States, 1999–2000. MMWR Morb Mortal Wkly Rep 2002;51: 80810.
  • 81
    Williams LJ, Mai CT, Edmonds LD, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 2002;66: 339.
  • 82
    Persad VL, Van den Hof MC, Dube JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 2002;167: 2415.